586 related articles for article (PubMed ID: 9372207)
21. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
Mansi JA; Rivest S; Drolet G
Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
[TBL] [Abstract][Full Text] [Related]
22. CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.
Varodayan FP; Correia D; Kirson D; Khom S; Oleata CS; Luu G; Schweitzer P; Roberto M
Neuropharmacology; 2017 Oct; 125():418-428. PubMed ID: 28807676
[TBL] [Abstract][Full Text] [Related]
23. Selective impairment of corticotropin-releasing factor1 (CRF1) receptor-mediated function using CRF coupled to saporin.
Maciejewski-Lenoir D; Heinrichs SC; Liu XJ; Ling N; Tucker A; Xie Q; Lappi DA; Grigoriadis DE
Endocrinology; 2000 Feb; 141(2):498-504. PubMed ID: 10650928
[TBL] [Abstract][Full Text] [Related]
24. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
25. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
27. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
[TBL] [Abstract][Full Text] [Related]
28. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats.
Million M; Grigoriadis DE; Sullivan S; Crowe PD; McRoberts JA; Zhou H; Saunders PR; Maillot C; Mayer EA; Taché Y
Brain Res; 2003 Sep; 985(1):32-42. PubMed ID: 12957366
[TBL] [Abstract][Full Text] [Related]
29. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
30. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist.
Heinrichs SC; De Souza EB; Schulteis G; Lapsansky JL; Grigoriadis DE
Neuropsychopharmacology; 2002 Aug; 27(2):194-202. PubMed ID: 12093593
[TBL] [Abstract][Full Text] [Related]
31. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
Verleye M; André N; Gillardin JM
Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145
[TBL] [Abstract][Full Text] [Related]
32. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
[TBL] [Abstract][Full Text] [Related]
33. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
Henry B; Vale W; Markou A
J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
[TBL] [Abstract][Full Text] [Related]
34. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
Martinez V; Barquist E; Rivier J; Taché Y
Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
[TBL] [Abstract][Full Text] [Related]
35. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
36. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
Miguel TT; Nunes-de-Souza RL
Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
[TBL] [Abstract][Full Text] [Related]
37. Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala.
Nie Z; Zorrilla EP; Madamba SG; Rice KC; Roberto M; Siggins GR
ScientificWorldJournal; 2009 Jan; 9():68-85. PubMed ID: 19151899
[TBL] [Abstract][Full Text] [Related]
38. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
[TBL] [Abstract][Full Text] [Related]
39. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.
Sahuque LL; Kullberg EF; Mcgeehan AJ; Kinder JR; Hicks MP; Blanton MG; Janak PH; Olive MF
Psychopharmacology (Berl); 2006 May; 186(1):122-32. PubMed ID: 16568282
[TBL] [Abstract][Full Text] [Related]
40. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
Tasma Z; Wills P; Hay DL; Walker CS
Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
